Molecular Research for Cancer Immunotherapy
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".
Deadline for manuscript submissions: 30 November 2024 | Viewed by 100
Special Issue Editor
Interests: immune cells in tumor microenvironment; lung cancer; head and neck squamous cell carcinoma; oral cancer; extracellular matrix; chemoimmunotherapy; immunotherapy; immune checkpoints inhibitors; cancer stem cells; immune evasion; immune related-resistance mechanisms
Special Issue Information
Dear Colleagues,
Given the significant advances in quality of life and survival for patients with advanced tumors that have come with immunotherapy becoming a therapy of choice, this Special Issue attempts to explore the latest findings in molecular research in cancer immunotherapy. Focusing on deepening our understanding of the molecular complexities that govern the interaction between tumors and immune cells, we invite contributions investigating the role of molecular pathways in tumor immune evasion, characterizing the immune tumor microenvironment, identifying new biomarkers, and highlighting innovative molecular-based immunotherapeutic approaches, such as immune checkpoint inhibitors, CAR-T cell therapy, and cancer vaccines. This Special Issue aims to allow for more the establishment of effective cancer immunotherapies.
Dr. Mariana Malvicini
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer immunotherapy
- tumor immune microenvironment
- tumor immune evasion
- adoptive cell therapies
- immune checkpoint inhibitors
- neoantigen-based vaccines
- chemoimmunoresistance
- primary immunoresistance
- adaptive immunoresistance
- tumor associated-macrophages
- tumor-immune crosstalk
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
